Sabry, Dalia <br/><br/>
Multifocal electroretinography and optical coherence tomography changes after repeated intravitreal bevacizumab (Avastin) in myopic choroidal neovascularization.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)  Mar 2013 
 - 598-605 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1539-2864 
<br/><br/><label>Standard No.: </label>10.1097/IAE.0b013e3182681066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bevacizumab<br/>Capillary Permeability<br/>Choroidal Neovascularization--drug therapy<br/>Electroretinography--drug effects<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Myopia, Degenerative--complications<br/>Prospective Studies<br/>Retreatment<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Visual Acuity--physiology